{"name": "Vanquish Oncology",
 "permalink": "vanquish-oncology",
 "crunchbase_url": "http://www.crunchbase.com/company/vanquish-oncology",
 "homepage_url": "",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": 2011,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "",
 "phone_number": "510-219-6200",
 "description": "",
 "created_at": "Mon Jun 03 12:13:17 UTC 2013",
 "updated_at": "Mon Jun 03 12:31:15 UTC 2013",
 "overview": "\u003Cp\u003EVanquish Oncology, Inc. develops drugs focused on targeting molecular defects in specific cancer cells to create personalized oncology therapeutics for unmet and underserved cancer markets. The company\u0026#8217;s product compounds target a cellular enzyme, procaspase-3, that when activated spurs reactions that kill the cancer cell. The company was incorporated in 2011 and is based in Champaign, Illinois.\u003C/p\u003E",
 "image": null,
 "products":
  [],
 "relationships":
  [],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$2.37M",
 "funding_rounds":
  [{"round_code": "partial",
    "source_url": "http://www.sec.gov/Archives/edgar/data/1572746/000157274613000001/xslFormDX01/primary_doc.xml",
    "source_description": "SEC",
    "raised_amount": 2369000.0,
    "raised_currency_code": "USD",
    "funded_year": 2013,
    "funded_month": 3,
    "funded_day": 25,
    "investments":
     []}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "2001 S. FIRST ST.",
    "address2": "SUITE 201",
    "zip_code": "61820",
    "city": "CHAMPAIGN",
    "state_code": "IL",
    "country_code": "USA",
    "latitude": 40.090271,
    "longitude": -88.2392429}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [],
 "external_links":
  []}